CNC Add to watchlist $37.58 +0.32 (+0.85%) Last updated: Apr 16, 2026 02:35
52-Week Range
$37.58
$25.08 $37.58 $64.15

Fundamentals Overview

Centene Corporation is in the middle of its 52-week range with low valuation, trading relatively flat today.

Valuation low

P/B 0.92 P/S 0.09

Intrinsic value (DCF)

+534.4% upside vs price

Risk (Beta)

0.59 — lower vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 53% confidence Risk: Lower Volatility — Beta 0.59. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +534.4% upside vs price

Pressures (Sell):

3M vs S&P 500: -19.6% · 3M vs Healthcare sector: -12.8%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$18.48B
P/E (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
52-Week Range
$25.08 - $64.15
Volume vs Avg
N/A
Beta
0.59

About

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled pr...
Sector: Healthcare
Headquarters: US
Employees: 60,400
IPO Date: Dec 2001
Beta: 0.59 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: C+. Recent institutional grades: mixed. Current institutional positions: Buy: 3, Equal Weight: 10, Hold: 1, Neutral: 11, Outperform: 3, Overweight: 1, Sell: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $238.37; current price is $37.58. That’s a +534.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) N/A
DCF value (model) $238.37 (534.4% upside)
PEG (TTM) N/A
P/B (TTM) 0.92
P/S (TTM) 0.09
P/FCF (TTM) 4.28
Liquidity & enterprise
Current Ratio (TTM) 1.68
Quick Ratio (TTM) 1.68
Cash Ratio (TTM) 0.83
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) -3.43%
Gross margin (TTM) 12.24%
Operating margin (TTM) -3.91%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CNC.

Analyst Sentiment at a Glance

C+ Sentiment Mixed
Buy 3Equal Weight 10Hold 1Neutral 11Outperform 3Overweight 1Sell 1
1 upgrade, 1 downgrade
Price Target Consensus
Current $37.58
Median $44.00
Consensus $45.67
Low consensus $38.00
High consensus $59.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
JP Morgan maintain Neutral Neutral 2026-03-19
Mizuho maintain Neutral Neutral 2026-03-11
Morgan Stanley maintain Equal Weight Equal Weight 2026-03-04
Wells Fargo maintain Equal Weight Equal Weight 2026-02-18
Cantor Fitzgerald maintain Neutral Neutral 2026-02-09
Wells Fargo maintain Equal Weight Equal Weight 2026-01-07
Barclays upgrade Equal Weight Overweight 2026-01-05
Bernstein maintain Outperform Outperform 2025-11-21
Wells Fargo maintain Equal Weight Equal Weight 2025-11-12
Barclays maintain Equal Weight Equal Weight 2025-11-04
JP Morgan maintain Neutral Neutral 2025-11-04
Goldman Sachs maintain Sell Sell 2025-10-31
TD Cowen maintain Hold Hold 2025-10-31
Cantor Fitzgerald maintain Neutral Neutral 2025-10-30
Truist Securities maintain Buy Buy 2025-10-30
UBS maintain Neutral Neutral 2025-10-30
Morgan Stanley maintain Equal Weight Equal Weight 2025-10-14
Mizuho maintain Neutral Neutral 2025-10-09
Wells Fargo maintain Equal Weight Equal Weight 2025-10-07
Barclays maintain Equal Weight Equal Weight 2025-09-12
Truist Securities maintain Buy Buy 2025-09-12
Bernstein maintain Outperform Outperform 2025-09-05
Barclays maintain Equal Weight Equal Weight 2025-09-04
Cantor Fitzgerald maintain Neutral Neutral 2025-08-26
Morgan Stanley maintain Equal Weight Equal Weight 2025-08-04
JP Morgan maintain Neutral Neutral 2025-07-29
Truist Securities maintain Buy Buy 2025-07-28
UBS maintain Neutral Neutral 2025-07-28
Cantor Fitzgerald downgrade Overweight Neutral 2025-07-28
Oppenheimer maintain Outperform Outperform 2025-07-28